Cello Group (CLL)
CLL Share PerformanceMore
|52 week high||115.00 07/09/16|
|52 week low||77.00 21/01/16|
|52 week change||17.50 (20.83%)|
|4 week volume||2,075,645 30/09/16|
Latest News« previous» nextMore
12/10/2016 - 07:00 RNS
RNS Number: 2642M Cello Group plc 12 October 2016 Cello Group plc Director appointment Cello Group plc (AIM: CLL; "Cello", "The Group"), the healthcare focused strategic marketing group, is pleased to announce the appointment of Chris Jones as Non-Executive Director, effective as of October 17 th 2016. After graduating from Cambridge University, Chris spen...
05/10/2016 - 16:32 RNS
RNS Number: 8106L Cello Group plc 05 October 2016 4 October 2016 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has received notification that on 4 October 2016, Jane Shirley, a director of Cello Health, bought 2,331 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a purchase price of 107.4 pence per...
28/09/2016 - 10:10 StockMarketWire
finnCap today initiates coverage of Cello Group PLC (LON:CLL) with a buy investment rating and price target of 132p.
23/09/2016 - 17:30 RNS
RNS Number: 7458K Cello Group plc 23 September 2016 23 September 2016 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has received notification that on 22 September 2016, Doug Edmonds, a director of Cello Signal, exercised options over 50,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at an e...
20/09/2016 - 14:40 StockMarketWire
N+1 Singer today reaffirms its buy investment rating on Cello Group PLC (LON:CLL) and raised its price target to 128p (f...
14/09/2016 - 14:00 Interactive Investor
AIM has just hit a two-year high, and income shares are in demand. Ben Hobson at Stockopedia has scoured the junior ma...
14/09/2016 - 07:45 StockMarketWire
Healthcare focused strategic marketing group Cello's revenues rose 5.0% to 80.9m in the six months to the end of June. Gros...
14/09/2016 - 07:00 RNS
RNS Number: 7477J Cello Group plc 14 September 2016 For Immediate Release 14 September 2016 Cello Group plc ('Cello' or the 'Group') Interim Results for the six months to 30 June 2016 Progress with growth strategy Cello Group plc (AIM: CLL; "Cello", "The Group"), the healthcare focused strategic marketing group, today announces its interim results for the six mo...
|Dividend yield||2.818 %|
Latest discussion posts More
“shares mag buy - courtesy of alliance trust newsletter Cello tunes in to US healthcare Exciting expansion plans across the pond Tom Sieber Marketing ...”▼
“No great shakes. A lot of talk but don't expect a great leap forward this year, as "expectations will be broadly achieved", with UK problems holding back the group. That was ...”▼
“Yes, could well be someone sniffing around. The talk at the agm of increasing the payout ratio was, presumably, intended to boost the sp and make the co less ...”▼
Codes & Symbols
|Symbols||CLL, LSE:CLL, CLL.L, CLL:LN, LON:CLL, XLON:CLL|